Elevation Oncology Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for...

Related Keywords

Australia ,United States ,Canada ,Shawnm Leland ,Valerie Malyvanh Jansen ,R Michael Carruthers ,Exchange Commission ,Elevation Oncology Inc ,Corporate Communications Investor Relations ,Caris Life Sciences ,Nasdaq ,Clinical Cancer Research ,Elevation Oncology ,Chief Executive Officer ,Clinical Cancer ,Caris Life ,Joseph Ferra ,Chief Financial Officer ,Chief Medical Officer ,Full Year ,Looking Statements ,Private Securities Litigation Reform Act ,Oncology Investor ,Corporate Communications ,Balance Sheet ,